{"id":"NCT00952341","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)","officialTitle":"A Phase III, Randomized, Multi-center, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Study the Safety, Tolerability and Efficacy of MK0869/Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With High-Dose Cisplatin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08-25","primaryCompletion":"2010-04-04","completion":"2010-05-05","firstPosted":"2009-08-06","resultsPosted":"2011-09-27","lastUpdate":"2017-06-02"},"enrollment":421,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chemotherapy-induced Nausea and Vomiting (CINV)"],"interventions":[{"type":"DRUG","name":"aprepitant","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo to aprepitant","otherNames":[]},{"type":"DRUG","name":"dexamethasone","otherNames":[]},{"type":"DRUG","name":"granisetron","otherNames":[]},{"type":"DRUG","name":"dexamethasone","otherNames":[]}],"arms":[{"label":"Aprepitant (MK-0869)","type":"EXPERIMENTAL"},{"label":"Standard Therapy","type":"PLACEBO_COMPARATOR"}],"summary":"This study will demonstrate and confirm the efficacy and safety of MK0869 for the treatment of chemotherapy-induced nausea and vomiting in Chinese patients.","primaryOutcome":{"measure":"Proportion of Participants With Complete Response 120 Hours Following Initiation of High-dose Cisplatin Chemotherapy in the Overall Phase of Cycle 1","timeFrame":"0 to 120 hours","effectByArm":[{"arm":"Aprepitant (MK-0869)","deltaMin":0.696,"sd":null},{"arm":"Placebo","deltaMin":0.57,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.007"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24276953"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":205},"commonTop":["White blood cell count decreased","Neutrophil count decreased","Constipation","Decreased appetite","Alanine aminotransferase increased"]}}